



































































































View Journal  | View IssueaVTT Technical Research Centre of Finland,
kirsi.bromann@vtt.; Fax: +358 20 722 707
bDivision of Pharmaceutical Chemistry, Facu
00014 University of Helsinki, Viikinkaari 5E
† Electronic supplementary information (E
See DOI: 10.1039/c3ay41640b
Cite this: Anal. Methods, 2014, 6, 1227
Received 21st September 2013
Accepted 10th December 2013
DOI: 10.1039/c3ay41640b
www.rsc.org/methods
This journal is © The Royal Society of CIsolation and purification of ent-pimara-8(14),15-
diene from engineered Aspergillus nidulans by
accelerated solvent extraction combined with
HPLC†
K. Bromann,*a K. Viljanen,a V. M. Moreira,b J. Yli-Kauhaluoma,b L. Ruohonena
and T. Nakari-Setäläa
We recently engineered Aspergillus nidulans to produce a pimarane-type diterpene, ent-pimara-8(14),15-diene.
Here, we describe methods for its isolation and purification from the engineered A. nidulans production strain
and extend these findings with structural confirmation for the diterpene from this fungal source. The extraction
protocol was optimized using accelerated solvent extraction (ASE) with three varying parameters: solvent
composition, pressure, and temperature. This ASE method using 100% ethyl acetate at 90 C with 12.07 MPa
was more efficient and faster compared to ultrasonic-assisted extraction. Using both analytical and
preparative C18 columns at isocratic elution of acetonitrile developed an HPLC separation; and, the
diterpene was well separated within 28 min and 35 min, respectively. Also, TLC of the fungal culture extracts
was performed with visualization using rhodamine. The reproduction and efficiency of the purification
methods were evaluated by GC-MS; and, the structure of the compound was verified by NMR. The method
enabled the isolation of this very lipophilic diterpene in pure form, allowing its testing in a number of
bioactivity assays. Notably, we demonstrate for the first time the antioxidant activity for ent-pimara-8(14),15-
diene using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay.Introduction
Aspergillus nidulans is a lamentous fungus widely used as a
model organism for studies of cell biology and gene regulation. It
is a close relative to other Aspergillus species with industrial and
medical signicance – e.g., A. niger, A. oryzae, A. avus, and
A. fumigatus. The genus Aspergillus produces a variety of natural
products, and offers a model system to study secondary metabo-
lism in eukaryotes.1 Secondary metabolites are microbial organic
compounds that are not crucial for the survival of the organism
but many times exhibit interesting or useful bioactivities. These
are also referred to as natural products. Major groups of
secondary metabolites include polyketides, ribosomal and non-
ribosomal peptides, and terpenoids. In fungi, the biosynthetic
genes of secondary metabolism are organized into clusters.2 The
clustering of the genes along with the sequenced genomes of
many Aspergillus species has accelerated the discovery of novel
natural products.3 Of the numerous secondary metabolites
produced by Aspergilli, the most notorious ones includeFI-02044 VTT, Tietotie 2, Finland. E-mail:
1; Tel: +358 40 067 5071
lty of Pharmacy, University of Helsinki, FI-
, Finland
SI) available: NMR spectra (Fig. 1S–6S).
hemistry 2014mycotoxins, such as A. avus aatoxin4,5 and A. carbonarius
ochratoxin.6,7 On the other hand, many of the Aspergillus natural
products also exhibit benecial properties and include the anti-
biotic penicillin8 and the cholesterol reducing agent lovastatin.9
Although the functional role of secondary metabolites in the
producing organism is oen unclear, it has been speculated that
secondary metabolites function as chemical signals in commu-
nication and defense to enhance the survival of the organism
within its ecological environment.10
Terpenoids are particularly interesting secondary metabo-
lites because of their many pharmaceutical and toxic bioactiv-
ities.11–13 Specically, oxygenated derivatives of pimaradiene
and kaurene have vasorelaxant, anti-inammatory, anti-micro-
bial and trypanocidal properties.14–19 Biosynthesis of fungal
natural products is regulated by environmental as well as
genetic factors.8 Recently, we reported that overexpression of a
Zn(II)2Cys6-type transcription factor in A. nidulans, called
pimaradiene biosynthetic cluster regulator (pbcR), led to
production of a diterpene hydrocarbon, ent-pimara-8(14),15-
diene.20 ent-Pimara-8(14),15-diene has previously been identi-
ed as a product of the rice (Oryza sativa subspecies japonica)
pimaradiene synthase, OsKSL5j.21 Many of the diterpene
hydrocarbons in rice, for example, ent-sandaracopimaradiene,
ent-cassa-12,15-diene, 9bH-pimara-7,15-diene, and stemar-13-

































































































View Article Onlinephytoalexins, which have been suggested to act as antibiotics.22
Also, ent-kaur-16-ene is a precursor of a diterpene phytohor-
mone gibberellic acid that regulates many aspects of develop-
ment in higher plants. However, the biological activity for
ent-pimara-8(14),15-diene in rice is still unknown, since OsKSL5
is not involved in the biosynthesis of diterpenoid phytoalexins
or gibberellins.23
In addition to higher plants, diterpene hydrocarbons have also
been found in fungi.20,24–26 For example, sandaracopimaradiene,
isopimara-8,15-diene and pimara-8(14),15-diene have previously
been identied among other terpene hydrocarbons in crude
extracts of the fungus Phomopsis amygdali.25 Also, many pimarane-
type diterpene hydrocarbons are found in the fungus Phoma betae,
where 8b-pimara-9(11),15-diene has been proposed to be an
intermediate in a biosynthetic pathway of aphidicolin, a specic
inhibitor of DNA polymerase a.26 The identication of different
diterpene hydrocarbons is many times based on the analysis of
terpene synthase products of in vitro enzyme assays;27–29 and, the
few reports on the identication of fungal diterpenes do not
report bioactivity assay data for these compounds.
Several techniques are used for isolation of oxygenated
terpenoids from crude plant and fungal extracts, such as silica
gel chromatography, reverse phase chromatography, vacuum
liquid chromatography, ash chromatography, preparative
thin-layer chromatography, capillary electrophoresis, and
recrystallization with methanol.11,30–32 These methods are most
suitable for terpenoids with functional groups, which add
hydrophilic properties to the compound and provide UV-
absorbent groups. ent-Pimara-8(14),15-diene is a very lipophilic
compound, and it does not have any functional groups or bonds
that have UV absorbance. The compound is not detectable
directly by UV uorescence. In this report we describe the
methods for isolation and purication of ent-pimara-8(14),15-
diene from A. nidulans by using ASE combined with reverse
phase HPLC. Compared to ultrasonic extraction, ASE was more
efficient and was further optimized for A. nidulans mycelia. GC-
MS was used to analyze the efficiency of the extraction methods
and the HPLC separation. We also describe a TLC separation
and rhodamine staining detection method, as well as structural
conrmation for A. nidulans ent-pimara-8(14),15-diene by NMR.
The purication methods enabled us to study the activity of
pure ent-pimara-8(14),15-diene in a number of bioactivity
assays. In DPPH radical scavenging assays, puried ent-pimara-
8(14),15-diene had higher activity than the known tetraterpene
antioxidant, beta-carotene, demonstrating for the rst time the
antioxidant activity of ent-pimara-8(14),15-diene. With our
production strain and purication method larger scale
production of ent-pimara-8(14),15-diene is possible.
Experimental
Aspergillus nidulans strains and culture media
A. nidulans FGSC A4 (Glasgowwild type, veA+)33was obtained from
the Fungal Genetics Stock Center (Kansas City, Missouri, USA)
and used as a wild type control strain. ent-Pimara-8(14),15-diene
producing strain, oe:PbcR, has been described earlier.20 Briey,
the genomic sequence of the Zn(II)2Cys6-type transcription factor1228 | Anal. Methods, 2014, 6, 1227–1234PbcR (AN1599.4, GenBank:BN001307) was cloned into a fungal
expression vector pKB1, where the expression of pbcR is under the
A. nidulans gpdA promoter. 20mg of linearized expression plasmid
DNA was transformed into A. nidulans FGSC A4 by protoplasting,
and the positive colonies were selected on minimal medium agar
plates with 200 mg mL1 of glufosinate ammonium. Strains were
grown in liquid YES-media (2% yeast extract, 4% sucrose) sup-
plemented with 3% gelatin at 30 C with 250 rpm.
Extraction
Extraction conditions of the sonication method have been
described earlier.20 Filtered and freeze-dried A. nidulans mycelia
were homogenized with a RetschMM301 Ball Mill at 29 Hz for 30–
60 s. The homogenized powder was mixed with diatomaceous
earth in ASE sample cells (Dionex) and extracted with ASE 200
(Dionex) using hexane : ethyl acetate (Hex : EtOAc) (1 : 1), EtOAc,
or acetonitrile (ACN). Extraction conditions were as follows:
pressure, 12.07 MPa or 15.51 MPa; temperature, 70 C, 80 C, or
90 C; preheat time, 1 min; heat time, 5 min; static time, 10 min;
ush volume, 30%; and purge time, 90 seconds. When assessing
the efficiency of the sonication and ASE methods, one batch of
mycelia was extracted three times with EtOAc.
Thin layer chromatography
An aliquot (200 mL) of the Hex : EtOAc (1 : 1) crude extract of
FGSC A4 (wild type) and oe:PbcR (pimaradiene producing
strain) was applied to silica plates (Silica Gel 60, Pre-coated TLC
Plates, Merck, Germany) and puried by thin-layer chromatog-
raphy. The separation was done with EtOAc : heptane : acetic
acid (9 : 90 : 1), and the different compound groups were visu-
alized under UV light aer spraying the silica plates with 0.01%
rhodamine 6B GO (Merck, Germany). The areas with different
compounds were marked with a pencil, and silica was scraped
and extracted with Hex : EtOAc (1 : 1). The purity of obtained
fractions was analyzed by GC-MS.
Gas chromatography-mass spectrometry
GC-MS analysis has been previously described by Bromann et al.
(2012).20 The separations were performed using an Agilent 6890
Series GC combined with a 5973 Network MS detector (Agilent,
USA) and a Combipal injector (Varian Inc., USA). Samples were
dissolved in EtOAc, injected in split mode (10 : 1) and separated
on a 25 m  0.2 mm  0.33 mm HP-1 capillary column (Agilent,
USA) with a helium ow rate of 1.3 mL min1. The ion source
temperature was 230 C, the interface was 280 C, and the oven
temperature was equilibrated at 100 C for 30 seconds and then
increased to 320 C at a rate of 10 C min1 and held at that
temperature for 25 minutes. The MS detector was operated in EI
mode at 70 eV with a mass range of 40–550. Compounds were
identied with the Palisade Complete 600K Mass spectral
library (Palisade Mass Spectrometry, USA).
High-performance liquid chromatography
A. nidulans oe:PbcR cell extracts were evaporated to dryness
and resuspended in HPLC grade ACN. Analytical HPLC wasThis journal is © The Royal Society of Chemistry 2014
Fig. 1 Comparison of relative yields of ent-pimara-8(14),15-diene
from two different extraction techniques. The sonication extraction (A)
recovers only 48.5% of ent-pimara-8(14),15-diene in the first extrac-
tion, whereas ASE (B) efficiently recovers 100% of the ent-pimara-

































































































View Article Onlineperformed using an XTerra MS C18 column (250  4.6 mm; 3.5
mm; Waters) with a Waters 616 pump with a Waters 600 S
system controller equipped with a Waters in-line degasser AF,
a Waters 717plus autosampler, a Waters 2996 photodiode
array detector (200–600 nm), and Waters Empower Pro chro-
matography soware for data processing (Milford, MA).
Samples were eluted with a ow rate of 0.5 mL min1. The
injected volume of the crude extract per run was 150 mL and
the total analysis time was set to 60 min. Preparative scale
purication was done using a Waters XTerra Prep MS C18
column (300  10 mm; 10 mm; Waters) with a 2 mL sample
loop and a 2.5 mL syringe (Waters). The injected volume was
2 mL of the crude extract and the ow rate was set to 2.5 mL
min1. The total analysis time was set to 60 min. The elution of
the different fractions was monitored at 225 nm, and the
collected fractions were evaporated to dryness under N2 ow at
30 C. Fractions were dissolved in a small volume of EtOAc and
the purity was analyzed by GC-MS.
DPPH radical scavenging assay
DPPH radical scavenging assay was performed according to
Kähkönen et al.34 with slight modications. Methanolic 0.1 mM
DPPH radical solution was mixed with ent-pimara-8(14),15-
diene or beta-carotene solution. The concentrations of pure
compounds were either 1 mM, 2.5 mM or 5mM. The absorption
at 517 nm was monitored up to 120 min using a UV-1800 UV-Vis
spectrophotometer (Shimadzu). The results were calculated as
the percentage of radicals scavenged at four different time-
points: 20, 60, 90, and 120 min.
IR, NMR, HRMS experimental
The IR spectrum was obtained using a Vertex 70 (Bruker Optics
Inc., MA, USA) FTIR instrument. The FTIR measurements were
made directly in solids with a horizontal Attenuated Total
Reectance (ATR) accessory (MIRacle, Pike Technology, Inc, WI,
USA). The transmittance spectrum was recorded at a 4 cm1
resolution between 4000 and 600 cm1 using the OPUS 5.5
soware (Bruker Optics Inc., MA, USA). ESI-MS was performed
by direct injection using a Synapt G2 HDMS (Waters, MA, USA)
instrument. NMR spectra were obtained using a Varian Mercury
Plus 300 spectrometer, in CDCl3 with tetramethylsilane (TMS)
as the internal standard. The chemical shis were reported in
parts per million (ppm) and on the d scale from TMS as an
internal standard. The coupling constants J are quoted in
hertz (Hz).
ent-Pimara-8(14),15-diene (1). IR (ATR) 3085, 2925, 2895,
1456, 1365, 912, 856 cm1. 1H-NMR (300 MHz, CDCl3) d 0.80 (s,
3H, 20-CH3), 0.85 (s, 3H), 0.88 (s, 3H), 1.01 (m, 1H, 5-H); 1.04 (s,
3H, 17-CH3), 1.70 (m, 2H), 2.05 (m, 1H, 7b-H), 2.26 (m, 1H, 7a-
H), 4.88 (dd, 1H, J1 ¼ 1.5 Hz and J2 ¼ 10.6 Hz, 16-Hb), 4.91 (dd,
1H, J1 ¼ 1.5 Hz and J2 ¼ 17.5 Hz, 16-Ha), 5.21 (s, 1H, 14-H), 5.78
(dd, 1H, J1¼ 10.6 Hz and J2¼ 17.5 Hz, 15-H). 13C-NMR (75 MHz,
CDCl3) d 14.9 (C20), 18.7, 19, 22 (C19), 22.5, 25.9 (C17), 33.2 (C4),
33.7 (C18), 34.6, 36 (C7), 37.3 (C13), 38.2 (C10), 39.3, 42.1, 50.6
(C9), 54.8 (C5), 109.8 (C16), 128.4 (C14), 137.2 (C8), 149.1 (C15).
HMRS calc. for C20H32 273.2582 [M + 1]
+, found 273.2578.This journal is © The Royal Society of Chemistry 2014Results and discussion
Previously, we reported the identication of the transcription
factor, PbcR, in A. nidulans. In the strain overexpressing pbcR
(oe:PbcR), transcription of seven genes within a cryptic
secondary metabolite gene cluster is activated; and, this results
in the production of a pimarane-type diterpene that we identi-
ed as ent-pimara-8(14),15-diene.20Comparison of extraction methods
In the current study, oe:PbcR mycelia were collected at the
exponential growth phase and then freeze-dried and homoge-
nized. To compare the previously reported sonication extraction
with ASE, we performed three serial extractions of the same
batch of mycelia using two methods. In GC-MS analysis of three
serial sonication extractions of manually ground mycelia with
Hex : EtOAc (1 : 1), 48% of ent-pimara-8(14),15-diene was
recovered in the rst extraction, 19% in the second extraction,
and 33% in the third extraction (Fig. 1A). In contrast, ASE effi-
ciently recovered 100% of ent-pimara-8(14),15-diene using one
extraction (Fig. 1B). Thus, automated homogenization of freeze-
dried mycelia and subsequent ASE proved to be superior for the

































































































View Article Onlineusing ASE is that weighing of the freeze-dried sample also
makes it possible to quantitate the extraction yield and method
efficiency.
The ASE method was optimized for the powdered sample by
using different solvent compositions, temperatures, and pres-
sures. The recovery of ent-pimara-8(14),15-diene was monitored
by analyzing GC-MS peak areas. We tested three different
solvents: Hex : EtOAc (1 : 1), 100% EtOAc, and ACN. The highest
relative recovery was marked as 100% extraction efficiency and
other peak areas were calculated as a percentage of this value.
The recovery of ent-pimara-8(14),15-diene from the fungal
mycelia was highest by using 100% EtOAc (Fig. 2A). Hex : EtOAc
was nearly as efficient (92%) in extracting ent-pimara-8(14),15-
diene as EtOAc, whereas ACN could extract only 52% of the ent-
pimara-8(14),15-diene compared to EtOAc (Fig. 2A).
The extraction method was further optimized with EtOAc by
testing at two different pressures: 12.07 MPa and 15.51 MPa.
Recovery of ent-pimara-8(14),15-diene was efficient at 12.07
MPa, and increasing pressure slightly lowered the yield (data
not shown), suggesting that pressure did not exert a great
inuence on extraction efficiency. Extraction with EtOAc at
three different temperatures (70 C, 80 C, and 90 C), with
12.07MPa pressure, demonstrated that the highest recovery was
achieved at 90 C (Fig. 2B). In a previous study, Kawamura
et al.35 reported that increasing temperature resulted in higherFig. 2 Influence of different solvents (A) and temperatures (B) on
recovery of ent-pimara-8(14),15-diene from oe:PbcR mycelia. The
error bars represent the standard error of the mean (SEM, n ¼ 3).
1230 | Anal. Methods, 2014, 6, 1227–1234recovery of paclitaxel from bark, although pressure was less
important for recovery. In their study, the temperature range
used for paclitaxel was 100–150 C, so it is possible that we
could have achieved higher recovery of ent-pimara-8(14),15-
diene using temperatures over 100 C. However, to prevent the
possible degradation of the compound, we did not test the
extraction at temperatures above 90 C. Taken together, our
data suggest optimal extraction conditions for ent-pimara-
8(14),15-diene from mycelia of oe:PbcR.Purication of ent-pimara-8(14),15-diene with TLC and HPLC
In order to isolate ent-pimara-8(14),15-diene from crude extracts
of oe:PbcR, a TLC method was developed. Mycelia from wild-
type A. nidulans (FGSC A4) and oe:PbcR were extracted, and the
extracts were separated on silica plates. ent-Pimara-8(14),15-
diene was visualized by rhodamine staining of the developed
silica plates (Fig. 3A), since the compound was not detectable
directly by UV uorescence. ent-Pimara-8(14),15-diene was
separated by using EtOAc : heptane : acetic acid (9 : 90 : 1).
Using this eluent composition, the compound moved along the
solvent front (Fig. 3A, lane 1). ent-Pimara-8(14),15-diene was
then extracted from the silica, and the purity of the compound
was analyzed by GC-MS (Fig. 3B and C). Many fatty acids and
other unknown interfering compounds that were present in the
crude extract (Fig. 3B) were not detected in the TLC puried
fractions (Fig. 3C). However, the TLC-puried compound still
contained some non-polar alkanes that interfered with identi-
cation by NMR analysis (Fig. 3C).
To further purify ent-pimara-8(14),15-diene, we developed an
analytical scale HPLC method. In HPLC, both the interactions
between the puried compound and the stationary phase as
well as the solvent play a role in the separation process.
Specically, ent-pimara-8(14),15-diene was puried from crude
extracts of oe:PbcR by reversed phase HPLC. The purication
method was tested by using three isocratic eluent compositions
of 85%, 90%, and 100% ACN; and efficient separation was
achieved with 100% ACN in one hour. Low wavelengths (190
nm, 210 nm, 225 nm, and 250 nm) were used to monitor frac-
tionation, because this diterpene hydrocarbon does not have
any functional groups or bonds that have UV absorbance; and,
the peak corresponding to ent-pimara-8(14),15-diene was not
detectable at wavelengths 250 nm and greater. To identify the
compound peak, eluent fractions were collected in six 10
minute intervals. ent-Pimara-8(14),15-diene was detected in the
third interval (20–30 minutes), and the individual peaks were
then collected and analyzed by GC-MS. The UV absorption
maximum for the peak corresponding to ent-pimara-8(14),15-
diene was 222.1 nm (Fig. 4A), and monitoring of the following
purications was done at 225 nm.
In the analytical scale HPLC, ent-pimara-8(14),15-diene was
eluted at 25 to 28 minutes aer the sample injection (Fig. 4B,
upper panel). Preparative scale HPLC was performed in order to
accommodate larger injection volumes. The chromatograms of
preparative scale and analytical scale HPLC were similar
(Fig. 4B), and the total analysis time was kept at 60 minutes. In
the preparative scale HPLC, the ent-pimara-8(14),15-diene peakThis journal is © The Royal Society of Chemistry 2014
Fig. 3 (A) TLC of crude Hex:EtOAc extracts of A. nidulans FGSC A4 (wild-type) and oe:PbcR. Separation was done using EtOAc : heptane : acetic
acid (9 : 90 : 1), and the developed silica plate was visualized with rhodamine staining. Compounds separated with TLC in oe:PbcR were (1) ent-
pimara-8(14),15-diene fraction, (2) organic acids, fatty acids, (3) organic acids, sugars, (4) aromatic carboxylic acids, fatty acids and alkanes, (5)
aromatic carboxylic acids and fatty acids. (B) GC-MS analysis of the oe:PbcR crude extract and (C) TLC purified fraction showed that some higher

































































































View Article Onlinewas detected at 30 to 35 minutes aer injection (Fig. 4B, lower
panel). The shoulder seen at the preparative scale HPLC peak
was not collected. Isolated ent-pimara-8(14),15-diene fractions
were combined, evaporated to dryness, and dissolved in EtOAc
prior to GC-MS analysis. Comparison of the GC-MS peak areas
for the crude extract and for the HPLC puried ent-pimara-
8(14),15-diene (Fig. 4C) indicated that there were no impurities
in the collected fraction; and, the recovery of the diterpene was
consistently over 90% (Fig. 4C, small panel). Aer multiple
rounds of preparative scale HPLC, 25 mg of pure compound was
collected.Bioactivity testing of ent-pimara-8(14),15-diene
With its isolation and purication, we could now test ent-
pimara-8(14),15-diene in a number of bioactivity assays. In
Aspergilli, the production of secondary metabolites has been
linked to oxidative stress.36,37 For example, lovastatin biosyn-
thesis in A. terreus, and aatoxin biosyntheses in A. parasiticus
and A. avus respond to accumulation of reactive oxygen species
(ROS) in these fungi.38,39 Because oxidative stress has also been
shown to activate secondary metabolite biosynthesis in
A. nidulans, we tested the anti-oxidant activity of pure ent-
pimara-8(14),15-diene hydrocarbon in a DPPH radical scav-
enging assay with three different concentrations and four time-This journal is © The Royal Society of Chemistry 2014points. We compared its activity to a known tetraterpene anti-
oxidant, beta-carotene. Pure ent-pimara-8(14),15-diene had
signicantly higher DPPH radical scavenging activity than beta-
carotene in all test conditions (Fig. 5).
Although the function of this compound in A. nidulans is
not known, the data suggest that one potential role of ent-
pimara-8(14),15-diene may be to function as an antioxidant.
The antioxidant activity of ent-pimara-8(14),15-diene could be
one way for A. nidulans to protect itself against stressful
situations where accumulation of free radicals inside the
cells occurs. We also tested puried ent-pimara-8(14),15-
diene for antimicrobial activity against Staphylococcus aureus,
and for inhibition of axenic amastigotes of Leishmania
donovani. However, even relatively high concentrations of the
compound (50 mM) were ineffective in both of these tests
(data not shown). Additional bioactivity and antioxidant
assays will give a more complete picture of the potential
bioactivity of the compound, and this will be addressed in
future studies.Structural analysis
To verify the structure of HPLC-puried ent-pimara-8(14),15-
diene, infra-red (IR), MS, and 1D and 2D NMR experiments were
performed (Table 1). Inspection of the 1H NMR spectrumAnal. Methods, 2014, 6, 1227–1234 | 1231
Fig. 4 (A) UV absorption maximum for ent-pimara-8(14),15-diene. (B) Chromatograms for analytical (upper panel) and preparative (lower panel)
HPLC purification for ent-pimara-8(14),15-diene. The peak corresponding to ent-pimara-8(14),15-diene eluted at 25 to 28 minutes in analytical
scale HPLC and at 30 to 35 minutes in the preparative scale HPLC. Shoulder seen at the preparative HPLC peak was not collected. (C) Gas
chromatograms for the crude extract of A. nidulans oe:PbcR (upper panel) and the HPLC purified ent-pimara-8(14),15-diene fraction (lower
panel). The yield of HPLC purified ent-pimara-8(14),15-diene from the crude extracts was over 90% (lower panel, small figure, error bar
represents the SEM, n ¼ 9).
Fig. 5 DPPH radical scavenging activities of ent-pimara-8(14),15-
diene (dark gray) and beta-carotene (light gray). The concentrations of
the pure compounds were 1 mM, 2.5 mM and 5 mM in the DPPH assay
with time points 20, 60, 90 and 120 minutes. ent-Pimara-8(14),15-
diene had higher antioxidant activity than beta-carotene. The error
bars represent the SEM (n ¼ 3).
Table 1 Selected NMR spectroscopic data for ent-pimara-8(14),15-
diene
Position dC, type dH (J in Hz)
4 33.2, C
5 54.8, CH 1.01, m
7a 36, CH2 2.26, m
7b 2.05, m
8 137.2, C
9 50.6, CH 1.70, m
10 38.2, C
13 37.3, C
14 128.4, CH 5.21, s
15 149.1, CH 5.78, dd (10.6, 17.5)
16a 109.8, CH2 4.91, dd (1.5, 17.5)
16b 4.88, dd (1.5, 10.6)
17 25.9, CH3 1.04, s

































































































View Article Onlineshowed the four methyl group signals as singlets at 0.80, 0.85,
0.88, and 1.04 ppm. The downeld double doublet at 5.78 ppm
was assigned to 15-H whereas the double doublets at 4.88 and1232 | Anal. Methods, 2014, 6, 1227–12344.91 ppm were assigned to 16-Hb and 16-Ha, respectively. Thus,
the signal at 4.88 ppm displayed the cis vicinal coupling
constant of 10.6 Hz between 16-Hb and 15-H and the geminalThis journal is © The Royal Society of Chemistry 2014


































































































View Article Onlinecoupling constant of 1.5 Hz. The trans vicinal coupling constant
for 16-Ha and 15-H was found to be 17.5 Hz.
The COSY spectrum displayed correlations between the
neighboring 15-H, 16-Ha, 16-Hb proton signals. The assignment
of C15 (149.1), C8 (137.2), C14 (128.4), and C16 (109.8) was
made by observation of their respective correlations on the
HSQC experiment. The signal at 1.70 ppm displayed correlation
to the signal at 50.6 ppm, belonging to a CH carbon, and was
assigned to 9-H.40 The remaining CH/CH3 signals to assign
correlated to the methyl group protons and to 5-H (C5 at 54.8
ppm). Assignment of the 17-methyl group to the signal at 1.04
ppm was based on the HMBC correlations with the signals of
C15, C14, and the quaternary carbon C13 at 37 ppm. The
remaining methyl group signals all displayed HMBC correla-
tions to C5. The signal at 0.80 ppm was assigned to the
20-methyl protons based on the HMBC correlations to C9 and
quaternary C10 (38.2 ppm). The signals at 0.85 and 0.88 ppm,
corresponding to the 19 and 18-methyl protons, both displayed
HMBC correlations to quaternary C4 (33.2 ppm). The stereo-
chemistry of ent-pimara-8(14),15-diene was veried by the
NOESY experiment. Selected NOESY correlations and a 3-D
presentation of ent-pimara-8(14),15-diene are depicted in
Fig. 6A and B, respectively. The axial position of the 13-methyl
group and b-orientation for 5-H and 9-H was conrmed by theThis journal is © The Royal Society of Chemistry 2014observed NOESY cross peaks of 14-H/17-CH3, 14-H/7a-H, and
16a-H/17-CH3, and is consistent with those found in the liter-
ature.41 Cross-peaks were also observed for the signals of 9-H
and 5-H. The assignment of C17 to the signal at 25.9 ppm is also
consistent with the axial position of this methyl group, as
opposed to the reported values of about 30 ppm for equatorial
orientation.42 These data conrm the structure and stereo-
chemistry of ent-pimara-8(14),15-diene isolated from A. nidulans
strain oe:PbcR, and are consistent with our earlier report.20 The
structure and the mass spectrum of pure ent-pimara-8(14),15-
diene are shown in Fig. 6C. NMR spectra are presented in the
ESI (Fig. 1S–6S).†
Conclusions
We developed isolation and purication methods for a lipo-
philic tricyclic diterpene, ent-pimara-8(14),15-diene, produced
in fungi. The optimized ASE and HPLCmethods developed here
were very reproducible and could be scaled up to accommodate
larger sample volumes. Biotechnological production of this
particular diterpene in A. nidulans and the purication methods
described here should enable production of large quantities of
pure ent-pimara-8(14),15-diene. This is necessary for more
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